Harry Hemingway is Professor of Clinical Epidemiology at University College London.
He is Director of the Farr Institute, London, funded by the MRC and nine other funders, representing a £39M investment in health informatics research, a member of the UCL Partners Informatics Board, Co-Investigator on the Administrative Data Research Centre, England, (£8m ESRC investment), and informatics lead for several Biomedical Research Centre initiatives.
His research focuses on cardiovascular disease in populations where new opportunities for large scale research arise from linking electronic health records, including the rich, longitudinal patient records in primary care, and hospital data from disease and procedure registries, as well as hospital episode statistics and mortality.
Harry’s group has led linkages of multiple record sources combined with scalable replicable approaches to ‘EHR phenotyping’ in the CALIBER programme (Lancet 2014a). The group have curated a data portal with metadata to establish replicable cohorts with several million person years of follow-up to address questions that are likely only to be addressed with such record linkages. Harry leads the UK Biobank Cardiac Outcomes working group tasked with delivering disease phenotypes from multiple linked electronic health record sources. Under Harry’s leadership, the prognosis research strategy (PROGRESS) group has published a four article series in BMJ and PloSMed 2013 and established an international initiative comparing care and outcomes after acute myocardial infarction (Lancet 2014b).
Harry was a Member of the NICE Guidelines committee on chest pain whose recommendations transformed the investigation of suspected stable angina. As a member of Myocardial Infarction National Audit Project (MINAP) Academic Group and a board member of National Institute of Cardiovascular Outcomes Research (NICOR), Harry has contributed to the governance and sharing of national registries for research which has directly informed policy and guidelines.